vs
Side-by-side financial comparison of Cambium Networks Corp (CMBM) and ImmunityBio, Inc. (IBRX). Click either name above to swap in a different company.
Cambium Networks Corp is the larger business by last-quarter revenue ($40.3M vs $38.3M, roughly 1.1× ImmunityBio, Inc.). Cambium Networks Corp runs the higher net margin — -17.9% vs -161.8%, a 143.9% gap on every dollar of revenue. On growth, ImmunityBio, Inc. posted the faster year-over-year revenue change (407.0% vs -23.2%). Cambium Networks Corp produced more free cash flow last quarter ($-10.8M vs $-71.3M).
Cambium Networks Corporation is an American manufacturer of wireless telecommunications equipment, including Enterprise WiFi, Network switch, Internet of Things, and fixed wireless broadband and Wi-Fi for enterprises products for Internet access. Publicly traded on the NASDAQ stock exchange, it spun out of Motorola in October 2011.
ImmunityBio, Inc. is a clinical-stage biotechnology company focused on developing next-generation immunotherapies and vaccine candidates targeting multiple cancer types and infectious diseases. It operates mainly in the U.S. market, with core R&D segments including cell therapy, antibody therapeutics, and targeted vaccine platforms designed to enhance patient treatment outcomes.
CMBM vs IBRX — Head-to-Head
Income Statement — Q4 FY2024 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $40.3M | $38.3M |
| Net Profit | $-7.2M | $-61.9M |
| Gross Margin | 36.6% | 99.0% |
| Operating Margin | -28.4% | -169.0% |
| Net Margin | -17.9% | -161.8% |
| Revenue YoY | -23.2% | 407.0% |
| Net Profit YoY | 71.0% | -4.7% |
| EPS (diluted) | $-0.26 | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $38.3M | ||
| Q3 25 | — | $32.1M | ||
| Q2 25 | — | $26.4M | ||
| Q1 25 | — | $16.5M | ||
| Q4 24 | $40.3M | $7.6M | ||
| Q3 24 | $44.7M | $6.1M | ||
| Q2 24 | $45.2M | — | ||
| Q1 24 | $47.1M | — |
| Q4 25 | — | $-61.9M | ||
| Q3 25 | — | $-67.3M | ||
| Q2 25 | — | $-92.6M | ||
| Q1 25 | — | $-129.6M | ||
| Q4 24 | $-7.2M | $-59.2M | ||
| Q3 24 | $-34.5M | $-85.7M | ||
| Q2 24 | $-14.2M | — | ||
| Q1 24 | $-18.4M | — |
| Q4 25 | — | 99.0% | ||
| Q3 25 | — | 99.4% | ||
| Q2 25 | — | 99.5% | ||
| Q1 25 | — | 99.6% | ||
| Q4 24 | 36.6% | — | ||
| Q3 24 | 43.6% | — | ||
| Q2 24 | 32.5% | — | ||
| Q1 24 | 29.8% | — |
| Q4 25 | — | -169.0% | ||
| Q3 25 | — | -173.5% | ||
| Q2 25 | — | -269.8% | ||
| Q1 25 | — | -390.1% | ||
| Q4 24 | -28.4% | -919.0% | ||
| Q3 24 | -69.6% | -1314.3% | ||
| Q2 24 | -27.2% | — | ||
| Q1 24 | -33.1% | — |
| Q4 25 | — | -161.8% | ||
| Q3 25 | — | -209.8% | ||
| Q2 25 | — | -350.3% | ||
| Q1 25 | — | -784.9% | ||
| Q4 24 | -17.9% | -783.4% | ||
| Q3 24 | -77.3% | -1404.0% | ||
| Q2 24 | -31.5% | — | ||
| Q1 24 | -39.2% | — |
| Q4 25 | — | $-0.06 | ||
| Q3 25 | — | $-0.07 | ||
| Q2 25 | — | $-0.10 | ||
| Q1 25 | — | $-0.15 | ||
| Q4 24 | $-0.26 | $-0.08 | ||
| Q3 24 | $-1.22 | $-0.14 | ||
| Q2 24 | $-0.51 | — | ||
| Q1 24 | $-0.66 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $242.8M |
| Total DebtLower is stronger | $67.6M | — |
| Stockholders' EquityBook value | $-3.2M | $-500.5M |
| Total Assets | $173.7M | $501.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $242.8M | ||
| Q3 25 | — | $257.8M | ||
| Q2 25 | — | $153.7M | ||
| Q1 25 | — | $61.6M | ||
| Q4 24 | — | $149.8M | ||
| Q3 24 | — | $130.4M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $67.6M | — | ||
| Q3 24 | $67.6M | — | ||
| Q2 24 | $68.9M | — | ||
| Q1 24 | $63.8M | — |
| Q4 25 | — | $-500.5M | ||
| Q3 25 | — | $-524.3M | ||
| Q2 25 | — | $-570.7M | ||
| Q1 25 | — | $-591.4M | ||
| Q4 24 | $-3.2M | $-489.1M | ||
| Q3 24 | $1.9M | $-745.1M | ||
| Q2 24 | $34.1M | — | ||
| Q1 24 | $45.0M | — |
| Q4 25 | — | $501.9M | ||
| Q3 25 | — | $519.0M | ||
| Q2 25 | — | $402.1M | ||
| Q1 25 | — | $303.8M | ||
| Q4 24 | $173.7M | $382.9M | ||
| Q3 24 | $194.3M | $364.6M | ||
| Q2 24 | $221.1M | — | ||
| Q1 24 | $219.8M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 36.12× | — | ||
| Q2 24 | 2.02× | — | ||
| Q1 24 | 1.42× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-10.4M | $-70.4M |
| Free Cash FlowOCF − Capex | $-10.8M | $-71.3M |
| FCF MarginFCF / Revenue | -26.8% | -186.2% |
| Capex IntensityCapex / Revenue | 1.1% | 2.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-21.4M | $-308.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-70.4M | ||
| Q3 25 | — | $-68.9M | ||
| Q2 25 | — | $-79.7M | ||
| Q1 25 | — | $-85.9M | ||
| Q4 24 | $-10.4M | $-85.1M | ||
| Q3 24 | $8.9M | $-98.8M | ||
| Q2 24 | $2.4M | — | ||
| Q1 24 | $-15.9M | — |
| Q4 25 | — | $-71.3M | ||
| Q3 25 | — | $-69.6M | ||
| Q2 25 | — | $-80.8M | ||
| Q1 25 | — | $-87.0M | ||
| Q4 24 | $-10.8M | $-87.3M | ||
| Q3 24 | $6.8M | $-101.6M | ||
| Q2 24 | $87.0K | — | ||
| Q1 24 | $-17.4M | — |
| Q4 25 | — | -186.2% | ||
| Q3 25 | — | -217.2% | ||
| Q2 25 | — | -305.9% | ||
| Q1 25 | — | -526.9% | ||
| Q4 24 | -26.8% | -1155.4% | ||
| Q3 24 | 15.2% | -1663.2% | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | -37.0% | — |
| Q4 25 | — | 2.4% | ||
| Q3 25 | — | 2.3% | ||
| Q2 25 | — | 4.1% | ||
| Q1 25 | — | 6.8% | ||
| Q4 24 | 1.1% | 28.0% | ||
| Q3 24 | 4.8% | 45.7% | ||
| Q2 24 | 5.1% | — | ||
| Q1 24 | 3.3% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CMBM
| Enterprise | $16.6M | 41% |
| Point To Multi Point | $16.4M | 41% |
| Other | $5.8M | 14% |
IBRX
Segment breakdown not available.
